Understanding and managing sepsis in patients with cancer in the era of antimicrobial resistance

C Gudiol, A Albasanz-Puig, G Cuervo… - Frontiers in …, 2021 - frontiersin.org
Sepsis is a frequent complication in immunosuppressed cancer patients and hematopoietic
stem cell transplant recipients that is associated with high morbidity and mortality rates. The …

[HTML][HTML] Prolonged vs short-term infusion of β-lactam antibiotics for the treatment of febrile neutropenia: a systematic review and meta-analysis

J Laporte-Amargos, M Ulldemolins, M Puig-Asensio… - Journal of Infection, 2023 - Elsevier
Background The optimization of the use of β-lactam antibiotics (BLA) via prolonged infusions
in life-threatening complications such as febrile neutropenia (FN) is still controversial. This …

Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial

FB Sime, MS Roberts, IS Tiong… - Journal of …, 2015 - academic.oup.com
Objectives The objectives of this study were to describe piperacillin exposure in febrile
neutropenia patients and determine whether therapeutic drug monitoring (TDM) can be …

Antibiotic resistance in cancer patients

C Gudiol, J Carratalà - Expert review of anti-infective therapy, 2014 - Taylor & Francis
Bacterial infection is one of the most frequent complications in cancer patients and
hematopoietic stem cell transplant recipients. In recent years, the emergence of …

[HTML][HTML] The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients

IC Gyssens, WV Kern, DM Livermore - haematologica, 2013 - ncbi.nlm.nih.gov
Haematologica has published European guidelines for empirical and targeted antibacterial
therapy for febrile neutropenic patients in the era of emerging resistance (ECIL-4). Indeed …

Effect of meropenem administration in extended infusion on the clinical outcome of febrile neutropenia: a retrospective observational study

C Fehér, M Rovira, A Soriano, J Esteve… - Journal of …, 2014 - academic.oup.com
Objectives Information on the efficacy of extended meropenem administration in neutropenic
patients is scarce. Our objective was to determine whether the administration of meropenem …

The prevention and management of infections due to multidrug resistant organisms in haematology patients

JA Trubiano, LJ Worth, KA Thursky… - British journal of …, 2015 - Wiley Online Library
Infections due to resistant and multidrug resistant (MDR) organisms in haematology patients
and haematopoietic stem cell transplant recipients are an increasingly complex problem of …

Management of febrile neutropenia in the era of bacterial resistance

S Alp, M Akova - Therapeutic advances in infectious disease, 2013 - journals.sagepub.com
Managing cancer patients with fever and neutropenia must be considered as a medical
emergency since any delay in initiating appropriate empirical antibacterial therapy may …

Altered pharmacokinetics of piperacillin in febrile neutropenic patients with hematological malignancy

FB Sime, MS Roberts, MS Warner, U Hahn… - Antimicrobial agents …, 2014 - Am Soc Microbiol
This study assessed the pharmacokinetics and dosing adequacy of piperacillin in febrile
neutropenic patients after the first dose. Pharmacokinetic analysis was performed using …

Using population pharmacokinetic modeling and Monte Carlo simulations to determine whether standard doses of piperacillin in piperacillin-tazobactam regimens are …

FB Sime, U Hahn, MS Warner, IS Tiong… - Antimicrobial Agents …, 2017 - Am Soc Microbiol
Changes in the pharmacokinetics of piperacillin in febrile neutropenic patients have been
reported to result in suboptimal exposures. This study aimed to develop a population …